RxDoctor Payments Data

Kendra Cross, APRN

Family · van Wert, OHNPI 1932722857

Payments from drug & device makers

$805in general payments, 2019–2025

Across 46 payments — averaging $17.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$265
  • AstraZeneca$101
  • Abbott$76
  • Pfizer$60
  • GSK$57
  • Lilly USA, LLC$42
  • plus $203 from 9 others

What the payments were for

  • Food & beverage$805100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$805 in reported general payments places this provider in the 65th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$200
Medicare patients
14
Services billed
31

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin20$32,309
OzempicSemaglutide22$21,143
TrulicityDulaglutide12$16,777
FarxigaDapagliflozin Propanediol19$15,477
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$10,419
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr22$10,263
Stiolto RespimatTiotropium Br/Olodaterol Hcl20$9,428
Ultra-Fine Micro Pen NeedlePen Needle, Diabetic11$1,381
Duloxetine Hcl20$656
Omeprazole85$493
Hydroxyzine Hcl38$462
Albuterol Sulfate HfaAlbuterol Sulfate36$436
Venlafaxine Hcl ErVenlafaxine Hcl12$382
Levothyroxine Sodium85$357
Buspirone Hcl19$267

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$101$25,89732 claims
Novo NordiskOzempic$15$21,14322 claims
Lilly USA, LLCTrulicity$42$16,77712 claims
GSKAnoro Ellipta$57$10,26322 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 6,812 family providers in Ohio.

Other family in van Wert

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →